2019 News Releases

View News Clips By Year
2020201920182017Archive
Drug-light combo could offer control over CAR T-cell therapy

Drug-light combo could offer control over CAR T-cell therapy

October 15, 2019

UC San Diego bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells. Full Story


Anticancer vaccines, natural language for computers, and multifunctional materials take center stage at UC San Diego Research Expo

Anticancer vaccines, natural language for computers, and multifunctional materials take center stage at UC San Diego Research Expo

March 14, 2019

The University of California San Diego Jacobs School of Engineering was just ranked the #11 graduate engineering program in the country by US News. Hear from more than 200 of these talented graduate students as they present their research at the 38th annual Jacobs School Research Expo, a showcase of the top engineering and computer science work underway at UC San Diego. Full Story


A bioengineered factory for T-cells

A bioengineered factory for T-cells

February 11, 2019

Researchers have developed an injectable sponge-like gel that enhances the production of T-cells after a bone marrow transplant, increasing the quantity and diversity of these key components of the immune system. This bioengineered device can be injected under the skin at the same time of the transplant to help revive the immune system after bone marrow transplantation.  Full Story


Micromotors deliver oral vaccines

Micromotors deliver oral vaccines

February 8, 2019

UC San Diego nanoengineering researchers have developed oral vaccines powered by micromotors that target the mucus layer of the intestine.  Full Story


Programming White Blood Cells to Fight Pancreatic Cancer

Programming White Blood Cells to Fight Pancreatic Cancer

February 5, 2019

Pancreatic cancer is the third most lethal cancer in the United States. Patients typically don’t know they have it until it’s too late, making it difficult to treat. Only 9 percent survive five years after diagnosis. But recent discoveries at the UC San Diego Institute of Engineering in Medicine are raising hope. Engineers and surgeons are working on a treatment by reprogramming white blood cells to target and eradicate pancreatic cancer tumors. Full Story


News Archive